MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-13-2026
Harvard Bioscience Operating Cash Flow 2011-2026 | HBIO
Annual Operating Cash Flow Harvard Bioscience
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.73 M | 1.44 M | 14 M | 1.15 M | 1.26 M | 9.33 M | 8.04 M | 2.88 M | 1.06 M | 5.38 M | 705 K | 4.35 M | 4.06 M | 8.06 M | 6.65 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 14 M | 705 K | 5.01 M |
Quarterly Operating Cash Flow Harvard Bioscience
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 2.99 M | - | - | - | 1.4 M | - | - | - | 1.81 M | - | - | - | -1.99 M | - | - | - | 1.04 M | - | 6.84 M | 5.24 M | 2.87 M | - | 5.82 M | 2.67 M | 2.01 M | - | 291 K | 1.72 M | 448 K | - | 2 M | -135 K | -610 K | - | 3.66 M | 216 K | -726 K | - | -1.06 M | -981 K | -497 K | - | 3.09 M | 2.49 M | 2.49 M | - | 2.81 M | - | 576 K | - | 6.66 M | 4.15 M | 1.6 M | - | 4 M | - | 1.14 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 6.84 M | -1.99 M | 1.94 M |
Operating Cash Flow of other stocks in the Medical instruments industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AtriCure
ATRC
|
57.3 M | $ 28.22 | -2.32 % | $ 1.35 B |  USA |
 |
Baxter International
BAX
|
845 M | $ 17.24 | 3.61 % | $ 8.84 B | USA |
 |
Atrion Corporation
ATRI
|
20 K | - | - | $ 810 M | USA |
 |
BioLife Solutions
BLFS
|
8.43 M | $ 19.71 | 3.03 % | $ 908 M | USA |
 |
Ekso Bionics Holdings
EKSO
|
-11.8 M | $ 8.73 | -3.64 % | $ 21.2 M | USA |
 |
Alcon
ALC
|
1.34 B | $ 77.31 | 3.54 % | $ 40.4 B |  Schweiz |
 |
Haemonetics Corporation
HAE
|
182 M | $ 59.53 | -0.05 % | $ 3 B | USA |
 |
The Cooper Companies
COO
|
796 M | $ 71.73 | 2.97 % | $ 14.3 B | USA |
 |
iRhythm Technologies
IRTC
|
80.9 M | $ 120.49 | 1.57 % | $ 3.86 B | USA |
 |
Isoray
ISR
|
-82.5 M | - | 0.03 % | $ 108 M | USA |
 |
Repro Med Systems
KRMD
|
462 K | $ 4.19 | -1.18 % | $ 194 M | USA |
 |
Masimo Corporation
MASI
|
196 M | $ 178.3 | -0.24 % | $ 9.5 B | USA |
 |
Microbot Medical
MBOT
|
-13 M | $ 2.35 | 2.62 % | $ 108 M |  Israel |
 |
Milestone Scientific
MLSS
|
-2.92 M | $ 0.27 | -4.66 % | $ 22.2 M | USA |
 |
Merit Medical Systems
MMSI
|
297 M | $ 69.24 | 2.73 % | $ 4.1 B | USA |
 |
electroCore
ECOR
|
-8.19 M | $ 6.21 | -7.45 % | $ 52.7 K | USA |
 |
Envista Holdings Corporation
NVST
|
276 M | $ 26.66 | 5.42 % | $ 4.48 B | USA |
 |
Pro-Dex
PDEX
|
-1.68 M | $ 48.97 | -1.63 % | $ 161 M | USA |
 |
Glaukos Corporation
GKOS
|
-57.8 M | $ 118.62 | 3.09 % | $ 5.75 B | USA |
 |
Predictive Oncology
POAI
|
-12.4 M | - | - | $ 31.1 M | USA |
 |
ICU Medical
ICUI
|
180 M | $ 123.92 | 3.41 % | $ 3.05 B | USA |
 |
InfuSystem Holdings
INFU
|
17.5 M | $ 9.47 | 1.18 % | $ 196 M | USA |
 |
Intuitive Surgical
ISRG
|
3.03 B | $ 462.28 | 2.06 % | $ 165 B | USA |
 |
ResMed
RMD
|
351 M | $ 230.7 | 2.06 % | $ 33.7 B | USA |
 |
LeMaitre Vascular
LMAT
|
81.3 M | $ 112.41 | 1.89 % | $ 2.54 B | USA |
 |
Retractable Technologies
RVP
|
-7.06 M | $ 0.68 | -4.59 % | $ 20.4 M | USA |
 |
Pulse Biosciences
PLSE
|
-54.1 M | $ 19.06 | -4.51 % | $ 1.28 B | USA |
 |
STAAR Surgical Company
STAA
|
-34.2 M | $ 20.88 | -1.0 % | $ 1.03 B | USA |
 |
STERIS plc
STE
|
1.15 B | $ 225.03 | 2.65 % | $ 22.2 B | USA |
 |
Stereotaxis
STXS
|
-13.7 M | $ 1.93 | 4.32 % | $ 176 M | USA |
 |
NeuroMetrix
NURO
|
-7.13 M | - | 5.05 % | $ 9.02 M | USA |
 |
Utah Medical Products
UTMD
|
14.7 M | $ 64.53 | 1.67 % | $ 209 M | USA |
 |
West Pharmaceutical Services
WST
|
755 M | $ 265.93 | 2.54 % | $ 19.2 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
235 M | $ 11.99 | 4.08 % | $ 2.39 B | USA |
 |
AngioDynamics
ANGO
|
-10.1 M | $ 10.17 | 4.85 % | $ 415 M | USA |
 |
Becton, Dickinson and Company
BDX
|
3.33 B | $ 157.09 | 1.37 % | $ 45.2 B | USA |
 |
Nephros
NEPH
|
827 K | $ 2.91 | 4.68 % | $ 30.2 M | USA |
 |
OraSure Technologies
OSUR
|
-49 M | $ 3.08 | 0.65 % | $ 226 M | USA |
 |
Repligen Corporation
RGEN
|
114 M | $ 119.77 | 3.89 % | $ 6.67 M | USA |